What does GynCARE Docteurs F. Closon et S. Verscheure do?

GynCARE Docteurs F. Closon et S. Verscheure is a specialist medical practice in Anthisnes. Private Limited, started on 10 May 2017, 1 establishment.

What is the address of GynCARE Docteurs F. Closon et S. Verscheure?

The registered office of GynCARE Docteurs F. Closon et S. Verscheure is located at Rue du Pas Bayard 20, 4163 Anthisnes.

Is GynCARE Docteurs F. Closon et S. Verscheure still active?

Yes. According to the CBE (18 September 2026) GynCARE Docteurs F. Closon et S. Verscheure is active, legal situation “Normale toestand”, started on 10 May 2017.

Is GynCARE Docteurs F. Closon et S. Verscheure registered on Peppol?

Yes, GynCARE Docteurs F. Closon et S. Verscheure is registered on the Peppol network with ID 0208:0675573623.

What is the enterprise number of GynCARE Docteurs F. Closon et S. Verscheure?

The enterprise number of GynCARE Docteurs F. Closon et S. Verscheure is BE0675573623.

When was GynCARE Docteurs F. Closon et S. Verscheure founded?

GynCARE Docteurs F. Closon et S. Verscheure was founded on 10 May 2017.

Who are the directors of GynCARE Docteurs F. Closon et S. Verscheure?

According to the 2024 annual accounts, the directors of GynCARE Docteurs F. Closon et S. Verscheure are: Sara Verscheure, François Closon.

Is GynCARE Docteurs F. Closon et S. Verscheure a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 May 2017; 4 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account.

How much profit did GynCARE Docteurs F. Closon et S. Verscheure make in 2024?

GynCARE Docteurs F. Closon et S. Verscheure posted a profit after taxes of € 155,486 in financial year 2024.

What is the revenue of GynCARE Docteurs F. Closon et S. Verscheure?

As a small company, GynCARE Docteurs F. Closon et S. Verscheure is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 287,856.

GynCARE Docteurs F. Closon et S. Verscheure (Private Limited)

Dossier GynCARE Docteurs F. Closon et S. Verscheure, printed on 18 September 2026 from databakkes.be/en/0675573623/gyncare-docteurs-f-closon-et-s-verscheure. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

GynCARE Docteurs F. Closon et S. Verscheure from Anthisnes, company number BE0675573623, closed financial year 2024 with a result of € 155,486 after tax. For that financial year GynCARE Docteurs F. Closon et S. Verscheure recorded a gross margin of € 287,856 and equity of € 556,994. Compared with financial year 2023, the result moved from € 185,795 to € 155,486. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2025.

What it is worth Growing

€ 556,994

▲ 39% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 155,486

▼ 16% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 436,892

▲ 11% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 550,794.

People and assets in 2024

Vehicles and equipment

€ 24,400

▼ 33% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 25,788

▼ 32% vs 2023

€ 12,311 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 11,388

▲ € 10,605 vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,631

▼ 90% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 236,517 Gross margin 2021: € 236,517 First fiscal year in the series	€ 287,425 Gross margin 2022: € 287,425 ▲ 22% vs 2021 (€ 236,517) Favourable step	€ 317,582 Gross margin 2023: € 317,582 ▲ 10% vs 2022 (€ 287,425) Favourable step	€ 287,856 Gross margin 2024: € 287,856 ▼ 9% vs 2023 (€ 317,582) Unfavourable step	▼ 9%
Profit after taxes	€ 166,451 Profit after taxes 2021: € 166,451 First fiscal year in the series	€ 151,202 Profit after taxes 2022: € 151,202 ▼ 9% vs 2021 (€ 166,451) Unfavourable step	€ 185,795 Profit after taxes 2023: € 185,795 ▲ 23% vs 2022 (€ 151,202) Favourable step	€ 155,486 Profit after taxes 2024: € 155,486 ▼ 16% vs 2023 (€ 185,795) Unfavourable step	▼ 16%
Equity	€ 134,511 Equity 2021: € 134,511 First fiscal year in the series	€ 255,713 Equity 2022: € 255,713 ▲ 90% vs 2021 (€ 134,511) Favourable step	€ 401,508 Equity 2023: € 401,508 ▲ 57% vs 2022 (€ 255,713) Favourable step	€ 556,994 Equity 2024: € 556,994 ▲ 39% vs 2023 (€ 401,508) Favourable step	▲ 39%
Total debts	€ 202,965 Total debts 2021: € 202,965 First fiscal year in the series	€ 233,785 Total debts 2022: € 233,785 ▲ 15% vs 2021 (€ 202,965) Unfavourable step	€ 199,925 Total debts 2023: € 199,925 ▼ 14% vs 2022 (€ 233,785) Favourable step	€ 93,195 Total debts 2024: € 93,195 ▼ 53% vs 2023 (€ 199,925) Favourable step	▼ 53%
Cash	€ 211,962 Cash 2021: € 211,962 First fiscal year in the series	€ 297,538 Cash 2022: € 297,538 ▲ 40% vs 2021 (€ 211,962) Favourable step	€ 392,100 Cash 2023: € 392,100 ▲ 32% vs 2022 (€ 297,538) Favourable step	€ 436,892 Cash 2024: € 436,892 ▲ 11% vs 2023 (€ 392,100) Favourable step	▲ 11%
Land & buildings	-	€ 22,006 Land & buildings 2022: € 22,006 First fiscal year in the series	€ 17,025 Land & buildings 2023: € 17,025 ▼ 23% vs 2022 (€ 22,006) Unchanged	€ 12,043 Land & buildings 2024: € 12,043 ▼ 29% vs 2023 (€ 17,025) Unchanged	▼ 29%
Retained profit	€ 128,311 Retained profit 2021: € 128,311 First fiscal year in the series	€ 249,513 Retained profit 2022: € 249,513 ▲ 94% vs 2021 (€ 128,311) Favourable step	€ 395,308 Retained profit 2023: € 395,308 ▲ 58% vs 2022 (€ 249,513) Favourable step	€ 550,794 Retained profit 2024: € 550,794 ▲ 39% vs 2023 (€ 395,308) Favourable step	▲ 39%
Dividend	€ 169,798 Dividend 2021: € 169,798 First fiscal year in the series	€ 30,000 Dividend 2022: € 30,000 ▼ 82% vs 2021 (€ 169,798) Unchanged	€ 40,000 Dividend 2023: € 40,000 ▲ 33% vs 2022 (€ 30,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 40,000) Unchanged	▼ 100%
Bank debt	€ 11,585 Bank debt 2021: € 11,585 First fiscal year in the series	€ 51,081 Bank debt 2022: € 51,081 ▲ € 39,496 vs 2021 (€ 11,585) Unfavourable step	€ 37,976 Bank debt 2023: € 37,976 ▼ 26% vs 2022 (€ 51,081) Favourable step	€ 25,788 Bank debt 2024: € 25,788 ▼ 32% vs 2023 (€ 37,976) Favourable step	▼ 32%
Balance sheet total	€ 337,476 Balance sheet total 2021: € 337,476 First fiscal year in the series	€ 489,498 Balance sheet total 2022: € 489,498 ▲ 45% vs 2021 (€ 337,476) Unchanged	€ 601,433 Balance sheet total 2023: € 601,433 ▲ 23% vs 2022 (€ 489,498) Unchanged	€ 650,188 Balance sheet total 2024: € 650,188 ▲ 8% vs 2023 (€ 601,433) Unchanged	▲ 8%

Key figures of GynCARE Docteurs F. Closon et S. Verscheure, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to GynCARE Docteurs F. Closon et S. Verscheure?

What happened at GynCARE Docteurs F. Closon et S. Verscheure in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2025 New annual accounts for financial year 2024: profit of € 155,486 (▼ 16% vs 2023). filed late Source: NBB ↗
May 10, 2017 New establishment in Anthisnes. KBO
May 10, 2017 Start of the company according to the CBE. KBO

In short

From € 166,451 profit in 2021 to € 155,486 profit in 2024.

Paid € 229,641 in corporate taxes since 2021.

Best year ever: 2023, with € 185,795 profit.

Paid out € 239,798 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at GynCARE Docteurs F. Closon et S. Verscheure? We notify you, reason included.

Follow GynCARE Docteurs F. Closon et S. Verscheure

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Sara Verscheure François Closon

GynCARE Docteurs F. Closon et S. Verscheure

Behind GynCARE Docteurs F. Closon et S. Verscheure are Sara Verscheure and François Closon.

See the full network in the app

Directors

According to the 2024 annual accounts

Sara Verscheure

Director

François Closon

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Pas Bayard 20

4163 Anthisnes

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0675.573.623
VAT number: BE 0675.573.623
Registered office: Rue du Pas Bayard 20, 4163 Anthisnes
Names & denominations: GynCARE Docteurs F. Closon et S. Verscheure · GynCARE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 10 May 2017
Peppol: Active · Active since 24 Nov 2023
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗